Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PROGRESS Trial: A Prospective, Randomized, Controlled Trial to Assess the Management of Moderate Aortic Stenosis by Clinical Surveillance or Transcatheter Aortic Valve Replacement

NCT04889872 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT04889872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04889872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PROGRESS Trial: A Prospective, Randomized, Controlled Trial to Assess the Management of Moderate Aortic Stenosis by Clinical Surveillance or Transcatheter Aortic Valve Replacement
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Recruiting
Start date
October 12, 2021
Completion date
June 30, 2037
Enrollment
2,250 (estimated)
Sites
80

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, calcific, aortic valve stenosis